FDA inspection
Jiangsu Hengrui Pharmaceuticals Co., Ltd.: FDA inspection ending Jun 2, 2023
FDA inspection 1209987 · No Action Indicated (NAI) · Lianyungang
Key facts
| Inspection ID | 1209987 |
|---|---|
| Firm | Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
| FEI number | 3011603969 |
| Address | Economic 567 3rd Fl., 3 Huaguoshan Road; And Technological Development Zone |
| City | Lianyungang |
| Fiscal year | 2023 |
| Inspection end date | Jun 2, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data